| 1 |
Bereswill S, Mousavi S, Weschka D, Buczkowski A, Schmidt S, Heimesaat MM. Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model. Biomolecules 2022;13. [PMID: 36671455 DOI: 10.3390/biom13010071] [Reference Citation Analysis]
|
| 2 |
Du K, Foote MS, Mousavi S, Buczkowski A, Schmidt S, Bereswill S, Heimesaat MM. Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice. Microorganisms 2022;10:1953. [PMID: 36296229 DOI: 10.3390/microorganisms10101953] [Reference Citation Analysis]
|
| 3 |
Bereswill S, Mousavi S, Weschka D, Heimesaat MM. Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis. Microorganisms 2021;9:1424. [PMID: 34209438 DOI: 10.3390/microorganisms9071424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis. Pathogens 2021;10:818. [PMID: 34209990 DOI: 10.3390/pathogens10070818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Xi, Hofmann L, Alter T, Einspanier R, Bereswill S, Heimesaat MM, Gölz G, Sharbati S. The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice. Gut Pathog 2021;13:42. [PMID: 34183045 DOI: 10.1186/s13099-021-00437-1] [Reference Citation Analysis]
|
| 6 |
Heimesaat MM, Weschka D, Mousavi S, Bereswill S. Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice. Int J Mol Sci 2021;22:6683. [PMID: 34206478 DOI: 10.3390/ijms22136683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Heimesaat MM, Mousavi S, Weschka D, Bereswill S. Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis-Results from a Preclinical Placebo-Controlled Intervention Study. Microorganisms 2021;9:1140. [PMID: 34070612 DOI: 10.3390/microorganisms9061140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
